Document is current
Any future updates will be listed below
-
Authors
Ngoumou, Gonza B.
Koppold, Daniela A.
Wenzel, Laetitia
Schirmaier, Anne
Breinlinger, Carolin
Pörtner, Lisa M.
Jordan, Stefan
Schiele, Julia K.
Hanslian, Etienne
Koppold, Annika
Stock-Schröer, Beate
Varvarezou, Dimitra M.
Jeitler, Michael
Ortiz, Miriam
Michalsen, Andreas
Stritter, Wiebke
Seifert, Georg
Kessler, Christian S.
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 22 December 2024
First Online: 23 January 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Charité - Universitaetsmedizin Berlin (protocol code EA1/125/22, date of approval 13.07.2022).
: Informed consent was obtained from all participants involved in the study.
: not applicable.
: The study was registered on the German Registry for clinical Trials (DRKS00031037).
: A.M., D.A.K. and E.H. are members of the steering board of the ÄGHEe.V. (German-Speaking Medical Association for Fasting and Nutrition). A.M. and D.A.K. have co-founded the Academy of Integrative Fasting (AIF), an institution for the qualification of medical staff in clinical fasting applications, and D.A.K. serves as a consultant for a mobile application on intermittent fasting (FASTIC) as well as a company producing plant-based supplements (EVERYYIN), while A.M. is co-founder of the company Salufast. C.K. is member of the scientific advisory board of Bruno Zimmer. All other authors declare no conflict of interest related to this manuscript.
